🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary goal of the study is to determine the safety and tolerability o...
Status
Completed
Location
Augusta University
Start Date
2015-09
Trial ID
NCT02712346
Treatments Being Tested
The purpose of this study is to investigate the effectiveness of a drug cal...
Status
Completed
Location
Nilanjana Bose, Md
Start Date
2010-02
Trial ID
NCT01072669
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of the com...
Status
Withdrawn
Location
Ochsner Clinic Foundation
Start Date
2017-10-12
Trial ID
NCT03309592
Treatments Being Tested
The purpose of this study is to find out if spironolactone added to ambrise...
Status
Terminated
Location
Brigham & Women's Hospital
Start Date
2015-09
Trial ID
NCT02253394
Treatments Being Tested
The objective of this study is to identify insulin-specific cerebral blood ...
Status
Completed
Location
University of Wisconsin, Madison
Start Date
2017-01-31
Trial ID
NCT02936687
This is a multicenter, randomized (2:1 oral treprostinil: placebo), double-...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT02999906
Treatments Being Tested
This is a randomized study of ambrisentan that will last 16 weeks. The stud...
Status
Terminated
Location
UT Southwestern Medical Center
Start Date
2009-01
Trial ID
NCT00840463
Treatments Being Tested
This research study is looking at the use of the drug ambrisentan and if it...
Status
Terminated
Location
National Jewish Health
Start Date
2012-09
Trial ID
NCT02169752
Treatments Being Tested